Since most patients with heart failure are re-admitted to the hospital, accurately identifying the risk of re-admission of patients with heart failure is important for clinical decision making and management. This study plans to develop an interpretable predictive model based on a Chinese population for predicting six-month re-admission rates in heart failure patients. Research data were obtained from the PhysioNet portal. To ensure robustness, we used three approaches for variable selection. Six different machine learning models were estimated based on selected variables. The ROC curve, prediction accuracy, sensitivity, and specificity were used to evaluate the performance of the established models. In addition, we visualized the optimized model with a nomogram. In all, 2002 patients with heart failure were included in this study. Of these, 773 patients experienced re-admission and a six-month re-admission incidence of 38.61%. Based on evaluation metrics, the logistic regression model performed best in the validation cohort, with an AUC of 0.634 (95%CI: 0.599–0.646) and an accuracy of 0.652. A nomogram was also generated. The established prediction model has good discrimination ability in predicting. Our findings are helpful and could provide useful information for the allocation of healthcare resources and for improving the quality of survival of heart failure patients.
FIFor The Alzheimer’s Disease Neuroimaging Initiative
For The Alzheimer’s Disease Neuroimaging Initiative
+4
Background: Predicting cognition decline in patients with mild cognitive impairment (MCI) is crucial for identifying high-risk individuals and implementing effective management. To improve predicting MCI-to-AD conversion, it is necessary to consider various factors using explainable machine learning (XAI) models which provide interpretability while maintaining predictive accuracy. This study used the Explainable Boosting Machine (EBM) model with multimodal features to predict the conversion of MCI to AD during different follow-up periods while providing interpretability. Methods: This retrospective case-control study is conducted with data obtained from the ADNI database, with records of 1042 MCI patients from 2006 to 2022 included. The exposures included in this study were MRI biomarkers, cognitive scores, demographics, and clinical features. The main outcome was AD conversion from aMCI during follow-up. The EBM model was utilized to predict aMCI converting to AD based on three feature combinations, obtaining interpretability while ensuring accuracy. Meanwhile, the interaction effect was considered in the model. The three feature combinations were compared in different follow-up periods with accuracy, sensitivity, specificity, and AUC-ROC. The global and local explanations are displayed by importance ranking and feature interpretability plots. Results: The five-years prediction accuracy reached 85% (AUC = 0.92) using both cognitive scores and MRI markers. Apart from accuracies, we obtained features’ importance in different follow-up periods. In early stage of AD, the MRI markers play a major role, while for middle-term, the cognitive scores are more important. Feature risk scoring plots demonstrated insightful nonlinear interactive associations between selected factors and outcome. In one-year prediction, lower right inferior temporal volume (<9000) is significantly associated with AD conversion. For two-year prediction, low left inferior temporal thickness (4) is the most important. During four-year prediction, APOE4 is the most critical. For five-year prediction, lower right entorhinal volume (<1000) is the most critical feature. Conclusions: The established glass-box model EBMs with multimodal features demonstrated a superior ability with detailed interpretability in predicting AD conversion from MCI. Multi features with significant importance were identified. Further study may be of significance to determine whether the established prediction tool would improve clinical management for AD patients.
Cardiovascular disease (CVD) is the leading cause of death worldwide. Low whole-grain intake is found to be one of the most important risk factors for cardiovascular disease development and progression. In this study, we focused on exploring the long-term trends of low whole-grain intake attributed to cardiovascular disease mortality in China during 1990–2019 and relative gender differences. Study data were obtained from the Global Burden of Disease (GBD) 2019 study. We used the age-period-cohort model to estimate the adjusted effect of age, period, and cohorts. Annual and average annual percentage changes were estimated by joinpoint regression analysis. We observed an increasing trend with a net drift of 1.208% for males and 0.483% for males per year. The longitudinal age curve suggested that the attributed rate increased for both genders. Period and cohort effects all suggested that the risk for males showed an increased trend that was higher than that of females. Our findings suggest that males and senior-aged people were at a higher risk of cardiovascular disease mortality attributed to low whole-grain intake. Effective strategies are needed to enhance people’s health consciousness, and increasing whole-grain intake may achieve a better preventive effect for cardiovascular disease.
Colorectal cancer is among the leading causes of cancer worldwide. Processed meat was known to be positively associated with a higher risk of gastrointestinal cancer. This study focused on the long-time trends of colorectal cancer mortality attributable to high processed meat intake in China from 1990 to 2019 and the projection for the next decade based on data obtained from the Global Burden of Disease 2019 study. We used an age-period-cohort model to fit the long-time trend. The joinpoint model was conducted to estimate the average and annual change of the attributable mortality. The Bayesian age-period-cohort model was used to project the crude attributable mortality from 2020 to 2030. An upward trend in colorectal cancer mortality attributable to high processed meat intake was observed for both sexes in China from 1990 to 2019, with an overall net drift of 4.009% for males and 2.491% for females per year. Projection analysis suggested that the burden of colorectal cancer incidence and mortality would still be high. Our findings suggested that colorectal cancer death attributable to high processed meat intake is still high in China, and elderly males were at higher risk. Gradually decreasing the intake of processed meat could be an effective way to reduce colorectal cancer mortality.
Introduction: To identify the key risk factors influencing in-ICU mortality of patients with sepsis and develop prognosis prediction models for patients with culture-positive sepsis (CPS) and culture-negative sepsis (CNS) patients.Material and methods: Data were extracted from the MIMIC-IV database, which included 9288 patients with sepsis. The whole sample was divided into CPS (6622 patients) and CNS groups (2666 patients). We established six machine learning models, including DT, RF, NB, XGB, GBDT and NNET, to predict in-ICU death for all study samples, CPS and CNS subgroups, respectively. Model performance were assessed using AUC, accuracy, sensitivity, and specificity. SHAP values were used to explain the effect of variables on model results.Results: The in-ICU mortality rate was 54.58% for the whole study sample, the difference in in-ICU mortality between the CPS (55.19%) and CNS (53.04%) groups was not statistically significant. Main Significant influential factors identified included Charlson comorbidity index (CCI), number of days in hospital, Glasgow Coma Scale (GCS), older age, total bilirubin (TBil). The XGB model performed best in the overall sample (AUC = 0.782), while the GBDT model was most effective for the CPS group (AUC = 0.7813) and the CNS group (AUC = 0.7582).Conclusions: This study identified key risk factors for in-ICU death in patients with sepsis and highlights differences in clinical characteristics between patients with CPS and CNS. These findings may contribute to the development of personalized treatment strategies and risk assessment, thereby improving the prognosis of septic patients, especially patients with CNS.